期刊文献+

局部麻醉药经聚乳酸羟基乙酸共聚物缓释给药的研究

Research on the local anesthetic administered by the poly (lactic-co-glycolic acid) sustained release system
原文传递
导出
摘要 背景临床常用局部麻醉药物的体内生物半衰期短,且局部组织的高药物浓度极易产生中枢神经和心血管毒性反应。目的综述局部麻醉药聚乳酸羟基乙酸共聚物[poly(1actic-co-gycolicacid),PLGA]缓释给药系统的研究进展。内容阐述PLGA相关研究,局部麻醉药PLGA微粒的类型与制备工艺,PLGA在不同动物实验模型的研究结果,临床研究进展及存在的缺陷和改进等四方面的相关内容。趋向局部麻醉药缓释系统的研究能够为临床提供更好的镇痛药物和麻醉方式,但是在载药量、生产工艺等方面还有待改进。 Background Local anesthetic commonly used in clinic has short biological half-life in vivo, and the high local drug concentration in tissue can easily produce central nervous system and cardiovascular toxicity. Objective To review the research progress of local anesthetic poly (lactic-co-glycolic acid)(PLGA) sustained release drug delivery systems. Content This paper reviews the researches in four areas, such as the research on PLGA, the type and preparation process of local anesthetic PLGA microparticles, the results in different experimental animal models and the progress of clinical research and the presence of defects and improvement. Trend Researches on local anesthetic delivery system can provide better clinical analgesic and anesthetic, but some qualities of the microparticles should be improved, such as the drug loading and the production process.
出处 《国际麻醉学与复苏杂志》 CAS 2015年第7期670-672,I0001,共4页 International Journal of Anesthesiology and Resuscitation
基金 福建省科技计划项目(2012Y0054)
关键词 局部麻醉药 聚乳酸羟基乙酸共聚物 微球 纳米粒 Local anesthetic Poly(lactic-co-glycolic acid) Microspheres Nanopartical
  • 相关文献

参考文献20

  • 1龚玉华,石海霞,吴洁,韩志强,陈冬梅,胡雅娟,武丽芳,辛学东.预充回流试验法预防硬膜外局麻药毒性反应与提高阻滞成功率的临床研究[J].国际麻醉学与复苏杂志,2010,31(6):495-498. 被引量:7
  • 2Weiniger CF, Golovanevski M, Sokolsky-Papkov M, et al. Review of prolonged local anesthetic action [J]. Expert Opin Drug Deliv, 2010, 7(6): 737-752.
  • 3Grayson AC, Voskerician G, Lynn A, et al. Differential degradation rates in vivo and in vitro of biocompatible poly (lactic acid) and poly (glycolic acid) homo-and co-polymers for a polymeric drug- delivery microchip [J ]. J Biomater Sci Polym Ed, 2004, 15 (10): 1281-304.
  • 4赵锋,高永良.聚乳酸微球生物降解机制和生物相容性研究进展[J].中国新药杂志,2002,11(1):67-71. 被引量:19
  • 5Kim JM, Seo KS, Jeong YK, et al. Co-effect of aqueous solubility of drugs and glycolide monomer on in Vitro release rates from poly (D, L -lactide -co -glycolide) discs and polymer degradation [ J ]. J Biomater Sci Polym Ed, 2005, 16(8): 991-1007.
  • 6Ramos Campos EV, Silva de Melo NF, Guilherme VA, et al. Preparation and characterization of poly (e -caprolactone) nanospheres containing the local anesthetic lidocaine [J]. J Pharm Sci, 2013, 102(1): 215-226.
  • 7Yin QQ, Wu L, Gou ML, et al. Long-lasting infiltration anaesthesia by lidocaine-loaded biodegradable nanoparticles in hydrogel in rats [ J ]. Acta Anaesthesiol Scand, 2009, 53 (9) : 1207-1213.
  • 8余让辉,陈仲清,陈辉,傅卫军,徐岩.罗哌卡因-醋酸地塞米松聚乳酸羟基乙酸共聚物微球药效学和药动学的观察[J].南方医科大学学报,2010,30(3):502-505. 被引量:4
  • 9钟延强,鲁莹,付强,吴伟,吴诚,高申,王新华.盐酸布比卡因PLGA微球蛛网膜下腔给药后的药效学及生物相容性研究[J].中华临床医药杂志(北京),2004,5(10):3-5. 被引量:2
  • 10Ratajczak-Enselme M, Estehe ]P, Dollo G, et al. Epidural, intrathecal and plasma pharmacokinetic study of epidural ropivacaine in PLGA-microspheres in sheep model [J:. Eur J Pharm Biopharm, 2009, 72(1): 54-61.

二级参考文献55

  • 1Grant G J, Piskoun B, Bansinath M. Analgesic duration and kinetic liposomal bupivacaine after subcutaneous injection in mice [J ]. Ciin Exp Pharmacol Phyaiol, 2003, 30(12): 966-8.
  • 2Rabin C, Liang Y, Ehrlichman RS, et al. In vitro and in vivo demonstration ofrisperidone implants in mice [J]. Schizophr Res, 2008, 98(1-3): 66-78.
  • 3Blanco MD, Bemardo MV, Sastre RL, et al. Preparation of bupivacaine-loaded poly (-caprolactone) microspheres by spray: drying drug release studies and biocompatibility [J]. Eur J Pharm Biopharm, 2003, 55(2): 229-36.
  • 4Zolnik BS, Burgess DJ. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres [J ]. J Control Rel, 2008, 127: 137-45.
  • 5Dan J Kopacz MD, Christopher M, et al. A modet to evaluate the pharmaeokinetie and pharmacodynamic variables of extended- release products using in vivo tissue microdialysis in humans:bupivacaineloaded mieroeapsules[J].Anesth Analg, 2003, 97(1): 124-31.
  • 6SeniorJ.RadomskyM.可注射缓释制剂[M].北京:化学工业出版社.2005:13-101.
  • 7Shikanov A, Domb AJ. Long acting local anesthetics-polymer formulation to prolong the effect of analgesia [ J ]. J Control Rel, 2007, 117(1): 97-103.
  • 8Hayashida M, Fukunaga A, Hanaoka K. An animal model for surgical anesthesia and analgesia: characterization with isoflurane anesthesia and remifentanil analgesia[J]. Anesth Analg, 2003, 97: 1340-6.
  • 9Mcdonald A, Faibushevich S, Gamick K, et al. Determination of local tissue concentrations of bupivacaine compounds on bupivacaine tissue clearance studied by microdialysis sampling [J]. Pharm Res, 2002, 19(11): 1745-2.
  • 10Estebe JP, Corre PL, Plessis LD, et al. The pharmacokinetics and pharmacodynamics ofbupivacaine-loaded microsphercs on a brachial plexusblock model in sheep [ J ]. Anesth Analg, 2001, 93: 447-55.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部